Archive - February 2020
As new coronavirus outbreaks emerge, fears of a global pandemic escalate
New AI-created antibiotic can kill many antibiotic-resistant bacteria
NHS to install ‘LIGHT’ proton therapy
Lilly’s Trulicity scores CV reduction indication in the US
Galderma’s investigational prurigo nodularis drug hits Phase II endpoint
BMS scores first oesophageal cancer nod for Opdivo in Japan
Esperion gets FDA thumbs up for cholesterol drug Nexletol
Lundbeck gets US approval for migraine drug at heart of Alder takeover
